106 related articles for article (PubMed ID: 3115278)
1. Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo.
Plata F; Garcia-Pons F; Wietzerbin J
Ann Inst Pasteur Immunol; 1987; 138(3):397-415. PubMed ID: 3115278
[TBL] [Abstract][Full Text] [Related]
2. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
Plata F; Wietzerbin J; Pons FG; Falcoff E; Eisen H
Eur J Immunol; 1984 Oct; 14(10):930-5. PubMed ID: 6208038
[TBL] [Abstract][Full Text] [Related]
3. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response.
Araujo Z; El Bouhdidi A; Heremans H; Van Marck E; Castés M; Carlier Y
Vaccine; 1999 Feb; 17(7-8):957-64. PubMed ID: 10067703
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
[TBL] [Abstract][Full Text] [Related]
6. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
[TBL] [Abstract][Full Text] [Related]
7. Resistance to Trypanosoma cruzi infection in mice does not necessarily correlate with production of interferon-gamma in vivo.
Meyer zum Büschenfelde C; Cramer S; Fleischer B; Frosch S
Med Microbiol Immunol; 1998 Oct; 187(2):107-13. PubMed ID: 9832325
[TBL] [Abstract][Full Text] [Related]
8. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.
Martins GA; Tadokoro CE; Silva RB; Silva JS; Rizzo LV
J Immunol; 2004 Apr; 172(8):4893-901. PubMed ID: 15067068
[TBL] [Abstract][Full Text] [Related]
10. Protected Trypanosoma cruzi infection in rats born to mothers receiving interferon-gamma during gestation is associated with a decreased intramacrophage parasite growth and preferential synthesis of specific IgG2b antibodies.
Didoli GL; Davila HO; Feldman S; di Masso R; Revelli SS; Bottasso OA
Int J Immunopharmacol; 2000 Jan; 22(1):45-55. PubMed ID: 10684988
[TBL] [Abstract][Full Text] [Related]
11. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
Silva JS; Twardzik DR; Reed SG
J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
[TBL] [Abstract][Full Text] [Related]
13. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi.
Petray PB; Rottenberg ME; Bertot G; Corral RS; Diaz A; Orn A; Grinstein S
Immunol Lett; 1993 Jan; 35(1):77-80. PubMed ID: 8458639
[TBL] [Abstract][Full Text] [Related]
15. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
18. Age-related increase in resistance to acute Trypanosoma cruzi infection in rats is associated with an appropriate antibody response.
Pascutti MF; Bottasso OA; Hourquescos MC; Wietzerbin J; Revelli S
Scand J Immunol; 2003 Aug; 58(2):173-9. PubMed ID: 12869138
[TBL] [Abstract][Full Text] [Related]
19. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced by a Trypanosoma cruzi soluble extract antigen in experimental Chagas' disease. Role of interferon gamma.
Garcia CA; Oliveira EC; Sakurada JK; Santos LM
Immunol Invest; 2000 Feb; 29(1):1-12. PubMed ID: 10709842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
